The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Scopolamine-Global Market Insights and Sales Trends 2025
Synopsis
Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
The global Scopolamine market size is expected to reach US$ 15 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029. The market is mainly driven by the significant applications of Scopolamine in various end use industries. The expanding demands from the Tablets, Injection and Patches,, are propelling Scopolamine market. Scopolamine Butylbromide, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Scopolamine Hydrobromide segment is estimated at % CAGR for the next seven-year period.
The major players in global Scopolamine market include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, etc. The top 3 players occupy about 55% shares of the global market. Australia and Europe are main markets, they occupy about 60% of the global market. Scopolamine Hydrobromide is the main type, with a share about 45%. Patches is the main application, which holds a share about 60%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Scopolamine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Scopolamine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Scopolamine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Scopolamine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Scopolamine covered in this report include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, Phytex Australia, Alchem International, Guangzhou Hanfang, Alkaloids Corporation and Luyin, etc.
The global Scopolamine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin
Global Scopolamine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Scopolamine market, Segment by Type:
Scopolamine Butylbromide
Scopolamine Hydrobromide
Others
Global Scopolamine market, by Application
Tablets
Injection
Patches
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Scopolamine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Scopolamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
The global Scopolamine market size is expected to reach US$ 15 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029. The market is mainly driven by the significant applications of Scopolamine in various end use industries. The expanding demands from the Tablets, Injection and Patches,, are propelling Scopolamine market. Scopolamine Butylbromide, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Scopolamine Hydrobromide segment is estimated at % CAGR for the next seven-year period.
The major players in global Scopolamine market include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, etc. The top 3 players occupy about 55% shares of the global market. Australia and Europe are main markets, they occupy about 60% of the global market. Scopolamine Hydrobromide is the main type, with a share about 45%. Patches is the main application, which holds a share about 60%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Scopolamine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Scopolamine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Scopolamine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Scopolamine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Scopolamine covered in this report include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, Phytex Australia, Alchem International, Guangzhou Hanfang, Alkaloids Corporation and Luyin, etc.
The global Scopolamine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin
Global Scopolamine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Scopolamine market, Segment by Type:
Scopolamine Butylbromide
Scopolamine Hydrobromide
Others
Global Scopolamine market, by Application
Tablets
Injection
Patches
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Scopolamine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Scopolamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Scopolamine Market Overview
1.1 Scopolamine Product Overview
1.2 Scopolamine Market Segment by Type
1.2.1 Scopolamine Butylbromide
1.2.2 Scopolamine Hydrobromide
1.2.3 Others
1.3 Global Scopolamine Market Size by Type
1.3.1 Global Scopolamine Market Size Overview by Type (2018-2029)
1.3.2 Global Scopolamine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Scopolamine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Scopolamine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Scopolamine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Scopolamine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Scopolamine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Scopolamine Sales Breakdown by Type (2018-2023)
2 Global Scopolamine Market Competition by Company
2.1 Global Top Players by Scopolamine Sales (2018-2023)
2.2 Global Top Players by Scopolamine Revenue (2018-2023)
2.3 Global Top Players by Scopolamine Price (2018-2023)
2.4 Global Top Manufacturers Scopolamine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Scopolamine Market Competitive Situation and Trends
2.5.1 Scopolamine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Scopolamine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Scopolamine as of 2022)
2.7 Date of Key Manufacturers Enter into Scopolamine Market
2.8 Key Manufacturers Scopolamine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Scopolamine Status and Outlook by Region
3.1 Global Scopolamine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Scopolamine Historic Market Size by Region
3.2.1 Global Scopolamine Sales in Volume by Region (2018-2023)
3.2.2 Global Scopolamine Sales in Value by Region (2018-2023)
3.2.3 Global Scopolamine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Scopolamine Forecasted Market Size by Region
3.3.1 Global Scopolamine Sales in Volume by Region (2024-2029)
3.3.2 Global Scopolamine Sales in Value by Region (2024-2029)
3.3.3 Global Scopolamine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Scopolamine by Application
4.1 Scopolamine Market Segment by Application
4.1.1 Tablets
4.1.2 Injection
4.1.3 Patches
4.2 Global Scopolamine Market Size by Application
4.2.1 Global Scopolamine Market Size Overview by Application (2018-2029)
4.2.2 Global Scopolamine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Scopolamine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Scopolamine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Scopolamine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Scopolamine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Scopolamine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Scopolamine Sales Breakdown by Application (2018-2023)
5 North America Scopolamine by Country
5.1 North America Scopolamine Historic Market Size by Country
5.1.1 North America Scopolamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Scopolamine Sales in Volume by Country (2018-2023)
5.1.3 North America Scopolamine Sales in Value by Country (2018-2023)
5.2 North America Scopolamine Forecasted Market Size by Country
5.2.1 North America Scopolamine Sales in Volume by Country (2024-2029)
5.2.2 North America Scopolamine Sales in Value by Country (2024-2029)
6 Europe Scopolamine by Country
6.1 Europe Scopolamine Historic Market Size by Country
6.1.1 Europe Scopolamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Scopolamine Sales in Volume by Country (2018-2023)
6.1.3 Europe Scopolamine Sales in Value by Country (2018-2023)
6.2 Europe Scopolamine Forecasted Market Size by Country
6.2.1 Europe Scopolamine Sales in Volume by Country (2024-2029)
6.2.2 Europe Scopolamine Sales in Value by Country (2024-2029)
7 Asia-Pacific Scopolamine by Region
7.1 Asia-Pacific Scopolamine Historic Market Size by Region
7.1.1 Asia-Pacific Scopolamine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Scopolamine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Scopolamine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Scopolamine Forecasted Market Size by Region
7.2.1 Asia-Pacific Scopolamine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Scopolamine Sales in Value by Region (2024-2029)
8 Latin America Scopolamine by Country
8.1 Latin America Scopolamine Historic Market Size by Country
8.1.1 Latin America Scopolamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Scopolamine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Scopolamine Sales in Value by Country (2018-2023)
8.2 Latin America Scopolamine Forecasted Market Size by Country
8.2.1 Latin America Scopolamine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Scopolamine Sales in Value by Country (2024-2029)
9 Middle East and Africa Scopolamine by Country
9.1 Middle East and Africa Scopolamine Historic Market Size by Country
9.1.1 Middle East and Africa Scopolamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Scopolamine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Scopolamine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Scopolamine Forecasted Market Size by Country
9.2.1 Middle East and Africa Scopolamine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Scopolamine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Alkaloids of Australia
10.1.1 Alkaloids of Australia Company Information
10.1.2 Alkaloids of Australia Introduction and Business Overview
10.1.3 Alkaloids of Australia Scopolamine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Alkaloids of Australia Scopolamine Products Offered
10.1.5 Alkaloids of Australia Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Information
10.2.2 Boehringer Ingelheim Introduction and Business Overview
10.2.3 Boehringer Ingelheim Scopolamine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Boehringer Ingelheim Scopolamine Products Offered
10.2.5 Boehringer Ingelheim Recent Development
10.3 Fine Chemicals Corporation
10.3.1 Fine Chemicals Corporation Company Information
10.3.2 Fine Chemicals Corporation Introduction and Business Overview
10.3.3 Fine Chemicals Corporation Scopolamine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Fine Chemicals Corporation Scopolamine Products Offered
10.3.5 Fine Chemicals Corporation Recent Development
10.4 Phytex Australia
10.4.1 Phytex Australia Company Information
10.4.2 Phytex Australia Introduction and Business Overview
10.4.3 Phytex Australia Scopolamine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Phytex Australia Scopolamine Products Offered
10.4.5 Phytex Australia Recent Development
10.5 Alchem International
10.5.1 Alchem International Company Information
10.5.2 Alchem International Introduction and Business Overview
10.5.3 Alchem International Scopolamine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Alchem International Scopolamine Products Offered
10.5.5 Alchem International Recent Development
10.6 Guangzhou Hanfang
10.6.1 Guangzhou Hanfang Company Information
10.6.2 Guangzhou Hanfang Introduction and Business Overview
10.6.3 Guangzhou Hanfang Scopolamine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Guangzhou Hanfang Scopolamine Products Offered
10.6.5 Guangzhou Hanfang Recent Development
10.7 Alkaloids Corporation
10.7.1 Alkaloids Corporation Company Information
10.7.2 Alkaloids Corporation Introduction and Business Overview
10.7.3 Alkaloids Corporation Scopolamine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Alkaloids Corporation Scopolamine Products Offered
10.7.5 Alkaloids Corporation Recent Development
10.8 Luyin
10.8.1 Luyin Company Information
10.8.2 Luyin Introduction and Business Overview
10.8.3 Luyin Scopolamine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Luyin Scopolamine Products Offered
10.8.5 Luyin Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Scopolamine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Scopolamine Industrial Chain Analysis
11.4 Scopolamine Market Dynamics
11.4.1 Scopolamine Industry Trends
11.4.2 Scopolamine Market Drivers
11.4.3 Scopolamine Market Challenges
11.4.4 Scopolamine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Scopolamine Distributors
12.3 Scopolamine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
